
New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

Low education is linked to significantly higher hip fracture death risk after surgery. New study highlights socioeconomic factors…

FDA approves Mounjaro for diabetes to reduce heart risks in adults. This new approval lowers risks of major…

Low education is linked to significantly higher hip fracture death risk after surgery. New study highlights socioeconomic factors…

Explore the $50 billion Rural Health Transformation Program: can it modernize care and solve rural hospital funding challenges?

FDA approves Mounjaro for diabetes to reduce heart risks in adults. This new approval lowers risks of major…

ACA marketplace changes threaten premium tax credits, pushing enrollees toward high‑deductible bronze plans that may cost thousands more…

Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply…

New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted…

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…